Study title: Briet, E et al. The prophylactiv treatment of hemophilia B Leyden with anabolic steroids. Ann. Intern. Med. 1985; 103: 225-226.Ann. Intern. Med. 1985; 103: 225-226Briet, E et al. The prophylactiv treatment of hemophilia B Leyden with anabolic steroids. Ann. Intern. Med. 1985; 103: 225-226.Ann. Intern. Med. 1985; 103: 225-226
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: TESTOSTERONE UNDECANOATE | |||||
ATC code: G03B A03 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |